Caseware UK (AP4) 2023.0.135 2023.0.135 2024-12-312024-12-312024-01-01falseprovision of childcare services under the Busy Bees brand.391386true SC118818 2024-01-01 2024-12-31 SC118818 2023-01-01 2023-12-31 SC118818 2024-12-31 SC118818 2023-12-31 SC118818 2023-01-01 SC118818 1 2024-01-01 2024-12-31 SC118818 1 2023-01-01 2023-12-31 SC118818 3 2024-01-01 2024-12-31 SC118818 3 2023-01-01 2023-12-31 SC118818 6 2024-01-01 2024-12-31 SC118818 6 2023-01-01 2023-12-31 SC118818 d:Exceptional 2024-01-01 2024-12-31 SC118818 d:Exceptional 2023-01-01 2023-12-31 SC118818 e:Director1 2024-01-01 2024-12-31 SC118818 e:Director1 2024-12-31 SC118818 e:Director2 2024-01-01 2024-12-31 SC118818 e:Director3 2024-01-01 2024-12-31 SC118818 d:Buildings 2024-01-01 2024-12-31 SC118818 d:Buildings 2024-12-31 SC118818 d:Buildings 2023-12-31 SC118818 d:Buildings d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 SC118818 d:Buildings d:ShortLeaseholdAssets 2024-01-01 2024-12-31 SC118818 d:Buildings d:ShortLeaseholdAssets 2024-12-31 SC118818 d:Buildings d:ShortLeaseholdAssets 2023-12-31 SC118818 d:Buildings d:LeasedAssets 2024-01-01 2024-12-31 SC118818 d:MotorVehicles 2024-01-01 2024-12-31 SC118818 d:MotorVehicles 2024-12-31 SC118818 d:MotorVehicles 2023-12-31 SC118818 d:MotorVehicles d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 SC118818 d:FurnitureFittings 2024-01-01 2024-12-31 SC118818 d:FurnitureFittings 2024-12-31 SC118818 d:FurnitureFittings 2023-12-31 SC118818 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 SC118818 d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 SC118818 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 SC118818 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 SC118818 d:CopyrightsPatentsTrademarksServiceOperatingRights 2024-12-31 SC118818 d:CopyrightsPatentsTrademarksServiceOperatingRights 2023-12-31 SC118818 d:ComputerSoftware 2024-12-31 SC118818 d:ComputerSoftware 2023-12-31 SC118818 d:IntangibleAssetsOtherThanGoodwill 2024-12-31 SC118818 d:IntangibleAssetsOtherThanGoodwill 2023-12-31 SC118818 d:CurrentFinancialInstruments 2024-12-31 SC118818 d:CurrentFinancialInstruments 2023-12-31 SC118818 d:Non-currentFinancialInstruments 2024-12-31 SC118818 d:Non-currentFinancialInstruments 2023-12-31 SC118818 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 SC118818 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 SC118818 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 SC118818 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 SC118818 d:ReportableOperatingSegment1 2024-01-01 2024-12-31 SC118818 d:ReportableOperatingSegment1 2023-01-01 2023-12-31 SC118818 d:UKTax 2024-01-01 2024-12-31 SC118818 d:UKTax 2023-01-01 2023-12-31 SC118818 d:ShareCapital 2024-12-31 SC118818 d:ShareCapital 2023-12-31 SC118818 d:ShareCapital 2023-01-01 SC118818 d:SharePremium 2024-12-31 SC118818 d:SharePremium 2023-12-31 SC118818 d:SharePremium 2023-01-01 SC118818 d:CapitalRedemptionReserve 2024-12-31 SC118818 d:CapitalRedemptionReserve 2023-12-31 SC118818 d:CapitalRedemptionReserve 2023-01-01 SC118818 d:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 SC118818 d:RetainedEarningsAccumulatedLosses 2024-12-31 SC118818 d:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 SC118818 d:RetainedEarningsAccumulatedLosses 2023-12-31 SC118818 d:RetainedEarningsAccumulatedLosses 2023-01-01 SC118818 d:AcceleratedTaxDepreciationDeferredTax 2024-12-31 SC118818 d:AcceleratedTaxDepreciationDeferredTax 2023-12-31 SC118818 d:OtherDeferredTax 2024-12-31 SC118818 d:OtherDeferredTax 2023-12-31 SC118818 e:OrdinaryShareClass1 2024-01-01 2024-12-31 SC118818 e:OrdinaryShareClass1 2024-12-31 SC118818 e:OrdinaryShareClass1 2023-12-31 SC118818 e:FRS101 2024-01-01 2024-12-31 SC118818 e:Audited 2024-01-01 2024-12-31 SC118818 e:FullAccounts 2024-01-01 2024-12-31 SC118818 e:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 SC118818 d:BetweenOneFiveYears d:ContractualUndiscountedValue 2024-12-31 SC118818 d:BetweenOneFiveYears d:ContractualUndiscountedValue 2023-12-31 SC118818 d:MoreThanFiveYears d:ContractualUndiscountedValue 2024-12-31 SC118818 d:MoreThanFiveYears d:ContractualUndiscountedValue 2023-12-31 SC118818 d:ContractualUndiscountedValue 2024-12-31 SC118818 d:ContractualUndiscountedValue 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: SC118818









BUSY BEES NURSERIES (SCOTLAND) LIMITED









ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

CONTENTS



Page
Strategic report
 
1 - 9
Directors' report
 
10 - 11
Directors' responsibilities statement
 
12
Independent auditor's report
 
13 - 15
Profit and loss account
 
16
Balance sheet
 
17 - 18
Statement of changes in equity
 
19
Notes to the financial statements
 
20 - 42


 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The directors present their strategic report for the year ended 31 December 2024.

Activities
 
The Company’s principal activity is the provision of childcare services under the Busy Bees brand. The Company is a wholly owned subsidiary of Eagle Superco Limited and, the Company with fellow subsidiaries, is collectively referred to as the Busy Bees group of companies (‘the Group’). The principal activity of the Group is the provision of childcare services.

Business review and future developments
 
The directors consider the Company to be a significant element of the Group.
The Group, including the Company, have demonstrated resilience and the operational and financial performance of the business has been strong during 2024 although the Company has experienced an element of labour shortages, which has temporarily impacted our ability to deliver occupancy growth in certain locations. In addition, the Company has experienced inflationary cost pressures although these have been mitigated by fee increases.
Turnover for the Company for the year was £20.2m (2023: £19.5m) and Earnings before interest, tax, depreciation and amortisation (EBITDA as defined below) was £4.5m (2023: £5.4m). Profit for the financial year was £2.3m (2023: £3.5m). Turnover for the year has increased as a result of increases in fees. EBITDA and profit decreased due to an increase in staff and other costs in excess of the fee increases. The directors are satisfied with the financial position of the Company, shareholder’s funds were £34.4m at 31 December 2024 (2023: £32.1m).
Key performance indicators for Busy Bees Nurseries (Scotland) Limited are places available and occupancy of those places. Average occupancy for the year ended 31 December 2024 was 66.3% (2023: 60.2%) being 1,135 full time equivalents (FTEs) (2023: 1,148 FTEs) on average places available of 1,713 FTEs (2023: 1,908 FTEs). The average occupancy in terms of FTEs is flat year in year, despite the places available having decreased during the year; this has resulted in a increase in the average occupancy percentage for 2024. The directors are satisfied with each KPI.
The directors expect the general level of performance to continue in the coming year, despite the challenges faced of the increase in national insurance contributions and the continued challenges in recruiting and retaining appropriately qualified employees, particularly centre-level qualified employees.



2024
2023

£000
£000


Operating profit
2,685
3,929

Add:

Depreciation on tangible fixed assets
1,005
879

Depreciation of right of use assets
601
637

Other (gains)/ loss on the sale of tangible fixed assets
167
(11)


EBITDA
4,458
5,434

Page 1

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

Business review and future developments (continued)
EBITDA is an alternative performance measure but considered an appropriate performance metric by the directors as it is a good indication of the cash generated by the business. EBITDA has reduced in the year as a result of a reduction in operating profit. Operating profit has reduced as a result of increased costs in excess of increased income in the year.
There is an unlimited cross guarantee between the Company and other group companies in respect of bank borrowings. The Group has a Senior Facilities Agreement (“SFA”) in place with GBP and Euro Term Loan B (“TLB”) loans of £365.9m and €932.1m respectively. On the 29 August 2025 an amend and extend process was completed on the Group's TLB loans to extend the term to February 2032. The TLB loans incur interest at SONIA + a margin and EURIBOR + a margin, dependent on the Group’s leverage ratio as reported by the Group to its lenders on a quarterly basis. For the majority of the year ended 31 December 2024, the Group was incurring interest at SONIA + 4.75% on the GBP loan and EURIBOR + 3.75% on the Euro loan. At the time of signing these financial statements, the Group is incurring interest at SONIA + 4.75% on the GBP loan and EURIBOR +3.75% on the Euro loan. The Group now has a £150.0m RCF facility with a term to August 2031, £24.0m of the RCF was drawn at 31 December 2024 and £16.0m was held for bank guarantees. At the time of signing the financial statements, the RCF facility incurs interest on any amount drawn at SONIA + 3.50%, and the Group has no additional amounts drawn of the RCF, but £16.0m held for guarantees and therefore has £134.0m of available RCF.

Section 172(1) Statement
 
The Group endeavours to follow high standards of corporate governance, with the board of Eagle Topco Limited (“Board”), an indirect parent company of the Company, determining the governance framework for the whole of the Group, including for the Company. In accordance with the Companies Act 2006 (the ‘Act’) (as amended by the Companies (Miscellaneous Reporting) Regulations 2018), the directors provide this statement describing how they have had regard to the matters set out in section 172(1) of the Act, when performing their duty to promote the success of the Company, under section 172.
The Board always aims to act in the best interests of the Company, and to be fair and balanced in its approach. The needs of different stakeholders are always considered as well as the consequences of any decision in the long-term and the importance of our internally published high standards of business conduct. More specific information is given in sub-paragraphs (a) to (f), which correspond to the individual factors disclosed under Section 172(1).
a) Long-term decision making
The Board maintains oversight of the Company’s performance, and reserves to itself specific matters for approval. In addition to this, any major decisions with long-term implications, including significant new business initiatives, would need shareholder approval under the Company Articles of Association, to ensure that the business decisions taken locally are in alignment with the long-term strategy of the Company. Any decisions approved either locally or by the Shareholders, are then implemented, with subsequent Board oversight to ensure these are in accordance with the agreed strategy.
b) Stakeholders: Employees
The Group pursues a policy of meeting with representatives of various sections of employees at which relevant information and developments are discussed. Full and fair consideration is given to applications for employment from disabled persons and to continuing the employment of those who become disabled while employed. The policy is to give equal opportunity for training, career development and promotion.
During 2024 and the prior period there were no employee consultations. Please refer to the statement of employee engagement below on page 4.
 
Page 2

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

c) Stakeholders: Customers, Suppliers, Others
Parents and children
The Group and Company strives to put our customers, our parents and their children, at the heart of our business through ongoing, honest and personal communications to parents about their children, their development and the wider business. The Group and Company communicates with parents through several channels which help to ensure the achievement of the Group’s Vision, to deliver the best start in life for each child which is aligned with what is important for our parents.
Net Promoter Score (NPS) programmes continue to be fully utilised and are now fully embedded across all  Strategic Business Units (SBU’s) and countries within which we operate, giving our marketing support teams daily real-time insight into parent’s satisfaction, as well as providing an actionable feedback loop with which our Centre and Operational Teams can directly and personally address individual parent comments.
Across the Group, we operate a number of parent facing apps (iConnect/Parent Zone in the UK for example), designed to support direct parent partnership with centres and educators and allowing instantaneous flow of information to parents about their children and their Busy Bees experience. The Group also actively encourages the development of relationships at centre level, with Parent Partnership Groups (including elected parents) meeting on a regular basis to encourage good communication between parents and the centre. Centre social media pages are also used to promote parent community and drive word-of-mouth and positive local reputation. From the start of a parent’s journey with us, our Customer Relationship Management (CRM) programmes allow customisable parent communications to help shape the parent enquiry management journey, allowing us to send communication (both operational and marketing) to parents centrally or at a centre level. Our CRM works hand in hand with our childcare management systems, which enables the business to keep its parents up to date with all key relevant information from the business as well as regular updates on the impact of Government guidance on how centres operate, and the safety measures taken to protect children and educators.
The Board recognises how fundamental the relationship with parents is to achieve the Group’s Vision and Mission. The Board ensures it is regularly briefed on key issues raised at a centre level by parents and decisions such as pricing, quality and curriculum tools and initiatives, all of which is reflected in discussions on the annual Operating Plan.
Suppliers
Suppliers are managed by Group Management on both a territory and Group basis, with the Board briefed regularly on significant supplier relationships or issues. Suppliers are important to our business because a steady supply of great value and quality goods and services enables our centres to deliver continuity of service to our families.
Each significant supplier is required to have a dedicated account manager, with a commitment to maintain regular meetings (at least quarterly) to assess the relationship and ensure consistent communication. We recognise the importance of good supplier management and are proactive in how we handle them. We are focused on ensuring we meet our payment terms with suppliers and measure of payment practice reporting. We have an established procurement process that ensures suppliers go through a level of diligence prior to being onboarded which includes, assessing the size of the Company, financial diligence, an assessment of the origin of products and supplies, submission of their Anti-Bribery and Corruption, Modern Slavery policies and any (where applicable) legal and industry standard accreditations. We also assess prospective suppliers’ ESG credentials giving preference to suppliers who are actively working to reduce their impact on the environment. We contractually mandate suppliers to reduce packaging to the bare minimum.
Significant suppliers, being those providing centre-facing products or services and critical infrastructure, and critical systems/software are required to observe key procurement principles in order to be listed as a preferred supplier. Tailored procurement principles are communicated to these suppliers clearly at the outset and during the relationship, covering quality standards, service levels, payment, price and margin transparency. In the UK, preferred suppliers are now mandated to be onboarded to our contract terms which cover and bind the suppliers to adhere to the standards of our key global policies and must submit their own accreditations, to us on an annual basis.
 
Page 3

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

d) Stakeholders: Community & Environment
The Group and Company engages with the community both centrally and locally, with centre directors given the autonomy to engage with their local communities to support local causes and issues. Centres are encouraged and supported to partner with local community causes, and local fund raising (often for families using our centres).
In the UK, the Group has partnered with Child Bereavement UK since 2018. The Group have raised over £260,000 for Child Bereavement UK with the help of our generous families and thoughtful staff teams during our partnership. In the UK, we offer support on a short-term basis by sharing our expertise and care with families in need. Key community initiatives are reported to the Board as part of the regular reporting structures in place.
During the year the Group finalised and reported its ESG strategy and initiatives. The Group’s environmental strategy focuses on reducing carbon emissions with a target to achieve net zero carbon by 2040, reducing energy and material consumption and improving procurement traceability. The Group’s social strategy includes a commitment to continue to deliver outstanding early years education, build upon our diverse and inclusive workforce, and to continue to support families in crisis as well as charity and community partners. We aim to continue to deliver exceptional governance across the Group and our governance programme, policies and procedures exist to help hold us accountable. As the Group grows and makes further acquisitions, our governance programme helps to maintain the cohesiveness of our organisation.
The Group’s environmental strategy focuses on reducing carbon emissions with a target to achieve net zero carbon by 2040, reducing energy and material consumption and improving procurement traceability. The Group’s social strategy includes a commitment to continue to deliver outstanding early years education, build upon our diverse and inclusive workforce, and to continue to support families in crisis as well as charity and community partners. We aim to continue to deliver exceptional governance across the Group and our governance programme, policies and procedures exist to help hold us accountable. As the Group grows and makes further acquisitions, our governance programme helps to maintain the cohesiveness of our organisation.
e) Reputation for high standards of business conduct
The Board is responsible for developing the corporate culture across the Company, which promotes integrity and transparency. The Company uses the same comprehensive systems of corporate governance and approves policies and procedures which promote corporate responsibility and ethical behaviour, as are implemented within Eagle Topco Limited and its subsidiaries. Central to these policies is the Code of Conduct. This applies to all directors and employees and is embedded into the Company’s operations.
f) Acting fairly as between members of the Company
The Board aims to understand the views of its shareholders and always to act in their best interests. In order to do this, the Board works closely with the principal shareholder on a very regular basis to ensure operations, strategy and performance are aligned with the long-term objectives of the shareholders, while complying with the Articles of Association of the Company.
Statement on Employee Engagement
The Group and Company values its workforce and considers its people to be our most important asset. We believe in supporting and investing in everyone who works at Busy Bees, and key to this is open communication with our people.
The Group has an independently administered whistleblowing helpline, ‘Speak Up’, which allows the workforce and other stakeholders to raise concerns if required.
The Group, with Board support and direction, has commenced a wider HR Strategy encompassing a diversity and inclusion strategy and succession planning strategy. Although Busy Bees is an equal opportunities employer, most organisations within our sector have a predominantly female front-line workforce. Whilst we celebrate a high percentage of women in leadership roles within our business, a goal for us remains to attract more male practitioners and managers to our Company. We firmly believe a diverse workforce will allow us to provide rich learning opportunities and effective role modelling to the children in our care and create a well-rounded pool of talent.
 
Page 4

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

Statement on Employee Engagement (continued)
During 2024 weekly management meetings across Europe were held, attended by the Group directors and UK National Support Centre management. The meetings facilitated the communication of key business and operational matters and also gave employees an opportunity to ask questions about the business, its strategy, and objectives, with the outcome disseminated through the business through the management structure. In addition to monthly data being available on dashboards, members of Group Management hold an annual update meeting for UK National Support Centre employees to attend where performance and department specific initiatives are presented.
The Group has internal communications for all employees and Centre Directors via a weekly communication summarising key business messages.
UK annual events are extended to centre level managers where they are invited to attend an annual managers’ awards ceremony, to recognise the achievements of the wider workforce during the year. The ceremony includes a Group update and a presentation on upcoming initiatives. The ceremony also provides an opportunity for networking, with senior managers (including Group Management) in attendance and available for managers to discuss issues of concern to them and raise questions.
Statement on Business Relationships
Investors
The Chairman and the respective investor directors ensure that the Board and the Group is made aware of the views of the significant investors and the issues relevant to them. The Group attaches significant importance to maintaining an effective engagement with investors to ensure a mutual understanding of investor and Board objectives and to deal with issues of concern. Consent is required from the ultimate controlling party, as per note 21, Ontario Teachers’ Pension Plan (OTPP) for certain key decisions, with communication on these matters led by the Chairman and the Group Chief Executive Officer. The Board and Group Management are also aware of and comply fully with the investor information requirements detailed in the Investment Agreement. The Board engage with investors through a number of formal Board and Committee mechanisms and in addition have a good working relationship with open communication between the Board, Senior Management and OTPP and Temasek.
Lenders
The Group, through the Group Management team and members of the Board, provide our bank lending syndicate with a quarterly covenant compliance certificate and quarterly accounts to ensure they are kept informed of business activities and progress. On an annual basis, the Group Chief Executive Officer and the Group Chief Financial Officer hold a lender presentation to provide them with an update on the Group and its strategy (both financial and operational) for the coming year. This was supplemented during the year when the Group sought to refinance and subsequently draw down additional funds under its SFA.
The Group also maintains regular ad hoc dialogue with the lending syndicate throughout the year (predominantly through the agent) to inform them of acquisitions and any other material changes in the business.
 
Page 5

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

Sector stakeholders - government and other regulatory bodies
As a leading childcare provider in the UK, the Group and Company places significant emphasis on its engagement with government representatives (local and central) as well as the key related regulatory and sector organisations. The Group actively engages in a positive way in many of the territories it operates in, with government at a ministerial, civil service and local level and regularly reviews its compliance with policy and funding requirements. Any changes to the legal and regulatory environment are captured as emerging risks through our risk management process with identified owners and action plans to ensure compliance when the changes come into effect. Our external legal advisers also provide detailed reviews in respect of existing and upcoming legislation that may affect the Group. A failure to comply could lead to unanticipated regulatory penalties or sanctions, as well as damage to our reputation. Engagement with these stakeholders affords the opportunity for Busy Bees to influence and affect policy through the collection of data, the amplification of our vision and demonstration of exemplary practice. The Group has a dedicated external affairs and government relations officer, who leads this interaction, to share knowledge, challenges and issues on behalf of the Group and the wider sector. 
This engagement, which includes round table discussions, regular meetings as well as reactive meetings and discussions provides us with government thinking and advice around sector regulation but also enables us to share pre-policy views and guidance, the aim of which is to influence the direction of regulation of the sector as a whole. The Board receives regular reports on all engagement with government across the Group, with the impact of external factors such as regulation of the sector and government funding of the sector reviewed and considered when making decisions around short term and long-term strategy for the Group.

Principal risks and uncertainties
 
People risk
The Company has noted an increase in the risk around the recruitment and retention of employees, particularly centre-level qualified employees during the current year and this is currently a principal risk for the Company. This increases the risk of not achieving the desired business performance, growth and quality as the Company may not have enough suitable employees to operate at the desired level and replacement employees may have less experience.
Alongside this, the Company has experienced increased wage and cost pressure due to increasing employee turnover, the increasingly competitive recruitment market and recruitment costs, and has built those into operating plans. The increase in this risk is due in part to macroeconomic factors, reducing the availability of suitably qualified and experienced employees.
In response to these pressures, additional Board reporting has been introduced to allow the Board to monitor the operational and financial impact more closely and take appropriate action as needed. The Company has access to the Group’s Education and Training capability in the UK, this not only allows the Company to offer high quality training to employees, but also to bring through a pipeline of apprentices to meet demand for childcare professionals.
The Company has a number of employee engagement channels which are utilised to monitor sentiment and adjust strategies, and has made an investment in employee renumeration and employee benefits, particularly for centre employees.
Credit risk
The directors manage the credit risk in the Company by requiring the majority of the parents whose children attend the Company’s nurseries to pay in advance and by carefully managing receivables exposure on all parents.
 
Page 6

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

Principal risks and uncertainties (continued)
Liquidity risk
The Group have a policy of maintaining sufficient cash balances required for working capital purposes to provide a buffer against liquidity and recessional risks. As a result of this policy and careful working capital management, the directors are able to ensure the Company has excess liquidity and is well placed to pay any suppliers as they fall due. 
The risks detailed below are those that are considered to effect the Group and are deemed relevant to this Company.
Market risk
Aside from the key risks facing most businesses, for example those of reputation and competition and market change, the Group, and therefore the company, considers its key risks to be as follows:
health and safety for young children in relation to which the Group has a dedicated compliance team that defines policy and procedure and closely monitors and reports compliance performance
change of government policy and the implementation of policy at a local level, including free entitlement funding. The Group actively engages in a positive way in many of the territories it operates in, with government at a ministerial, civil service and local level and regularly reviews its compliance with policy and funding requirements. Any changes to the legal and regulatory environment are captured as emerging risks through our risk management process with identified owners and action plans to ensure compliance when the changes come into effect. Our external legal advisers also provide detailed reviews in respect of existing and upcoming legislation that may affect the Group. A failure to comply could lead to unanticipated regulatory penalties or sanctions, as well as damage to our reputation.
cyber attack/(s) on our IT environment leading to loss of personal data and company information, as well as ongoing disruption to business operations. The Group has formalised disaster recovery plans, ongoing training, data protection controls and review of IT processes as well as stress testing of IT systems.
the medium to longer term impact of the wider economy in relation to recession, cost of living and inflation and the impact on the affordability of childcare which has increased in terms of likelihood and impact during the year.

Going concern

In preparation of the financial statements, the directors have made an assessment of the Group’s and the Company’s ability to continue as a going concern. The Company’s business activities, together with the factors likely to affect its future development, performance and position and its exposures to credit risk are set out above. The Company is dependent on the ability of other group companies to settle their obligations to the Company on a timely basis.
The Company made a profit after taxation of £2.3m (2023: £3.5m) and has net assets of £34.4m (2023: £32.1m). The Company is financed through an inter-company facility with other wholly-owned group companies, and there is an unlimited cross guarantee between the Company and other group companies in respect of bank borrowings. 
The Company is reliant on the support of its ultimate parent Company, Eagle Superco Limited, to be able to meet its liabilities as they fall due. However, the directors consider that the Company is an integral part of Eagle Superco Limited structure and strategy, which is evidenced by a letter of comfort from Eagle Superco Limited, which states its commitment to provide necessary financial support to ensure that the Company is a going concern for at least twelve months from the date of approval of these financial statements. 
 
Page 7

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

Going concern (continued)
The Group has existing TLB loans of £365.9m and €932.1m under its SFA. In addition, the Group had a £100.0m RCF facility up to 29 August 2025, at which point the facility has been increased to £150.0m. The TLB loans expire in February 2032, the RCF facility expires in August 2031. The TLB loans are a ‘cov-lite’ facility meaning there are no leverage covenant tests on the Group’s financing other than if more than 40% of the Group’s RCF facility is drawn. In this scenario, a leverage covenant of Group indebtedness to EBITDA of 9.85 times would apply.
During the year, the Group drew down on its RCF facility to fund acquisitions completed during the year. The maximum amount drawn at any one time was £38.0m. The amount drawn at 31 December 2024 was £24.0m; an amount of £16.0m is held for bank guarantees leaving available undrawn RCF facility of £60.0m at 31 December 2024. In the year to 31 December 2024 the Group made a loss after tax of £79.7m and has net liabilities of £595.9m, but has EBITDA of £269.9m.
The Group has prepared detailed forecasts for the period up to September 2026 which demonstrate that the Group is able to generate sufficient cash flows to operate within its financing arrangements. These assumptions are made by management based on recent performance, external forecasts and management’s knowledge and expertise of the Group’s cashflow drivers. The Group’s forecasts include the effect of changes in government funding from 2025, increases in employment and other costs realised or expected to be realised during 2025 and 2026 and expected increases in income as a result of planned price increases and expected occupancy growth. The forecast excludes any non-committed future acquisitions and developments.
The forecast demonstrated that the Group is able to operate within its financing arrangements. The covenant compliance ratio at December 2024 is 4.4:1 vs a maximum ratio of 9.85:1. EBITDA at 31 December 2024, as per lender reporting requirements, would need to fall by 54% in order to breach forecast covenant compliance. The Group cannot predict the indirect impact of any potential economic slowdown or other events, and the below sensitivities are deemed sufficiently robust in light of current global macro-economic developments in the US following the market response to state enforced tariffs. Having reviewed the Group’s principal risks, the most significant impact on the Group’s cashflows would be a combination of the Group’s principal risks materialising in a temporary or prolonged reduction in occupancy, and consequently, cashflows. The current forecast is based on the Group’s 2025 operating plan and thereafter the Group’s longer term forecasts. To assess any potential impact on the Group’s cashflows and liquidity, various sensitivities have been performed reflecting a reduction in occupancy rates, including occupancy falling up to 7% below the current forecast. This reduction in occupancy is considered a reasonable reduction to sensitise the Group’s cashflows as it is based on the Group’s previous experience of occupancy trends following the impact of global economic slowdowns. In combination with sensitising the impact of a fall in occupancy, the Group has also sensitised the Group’s cashflows in 2026 to the specific principal risk of further cost and interest cost increases. Cost increases of a further 2%, from higher than expected employee costs and other supply costs above those already included within the Group’s forecast which reflects all announced UK employment tax changes as at December 2024.
The Group has also sensitised higher than expected interest costs over what has been included in the forecast by modelling a slower than expected fall in SONIA/ EURIBOR rates, with a delay of three months, which is broadly comparable with actual SONIA/ EURIBOR rate performance in 2024. To offset the effect of these items, the Group has modelled the affect of removing planned capital expenditure cashflows on new sites in FY25 and FY26. Under the combination of these sensitivities, and with occupancy falling to 7% below the current forecast, the Group would have a minimum liquidity headroom, inclusive of the available undrawn RCF facility, of £135.2m in the forecast period and would remain in compliance with the leverage test covenant within its SFA. The impact of other mitigating actions, such as reducing development capital expenditure and reducing head office costs, which could protect cashflow and profitability have not been modelled and would be available as further mitigating actions to preserve liquidity.
In the period to August 2025, the Group has performed ahead of forecast in relation to cashflows. At 31 August 2025 the Group has no additional amounts drawn of the RCF, but £16.0m held for guarantees and therefore has £134.0m of available RCF.
 
Page 8

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

Going concern (continued)
As a consequence, the directors believe that the Group is well-placed to manage its business risks successfully and have a reasonable expectation that the Group and Company have adequate resources to continue in operational existence for the foreseeable future, being not less than 12 months from date of approval of these financial statements. Accordingly, the directors continue to adopt the going concern basis in preparing the annual report and financial statements.
After making inquiries and taking account of the factors noted above, the directors have a reasonable expectation that the Company will have access to adequate resources to continue in existence for the foreseeable future. Accordingly, the Company continues to adopt the going concern basis in preparing the annual report and financial statements.


This report was approved by the board and signed on its behalf.





M P Muller
Director

Date: 26 September 2025

Page 9

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The directors present their report and the financial statements for the year ended 31 December 2024. Details of the Directors’ assessment of future developments, going concern, engagement with stakeholders including employees, suppliers, customers and others and financial risks are set out in the strategic report.

Results and dividends

The profit for the year, after taxation, amounted to £2,259,000 (2023: £3,490,000).

The directors do not recommend payment of a final dividend (2023: £nil). No dividend has been paid since the year end.

Post balance sheet events

There have been no significant events affecting the Company since the year end.

Directors

The directors who served during the year and up to the date of this report were:

C J Creaser (resigned 3 September 2025)
M G P Davies 
M P Muller 
C A McCandless (appointed 3 September 2025)

Qualifying third party indemnity provisions

The Company has made qualifying third party indemnity provisions for the benefit of its directors, which were made during the year and remain in force at the date of this report. The provisions made by the Company are in force for the benefit of one or more directors of associated companies.

Political contributions

During the year, there were no political donations (2023: £nil).

Charity contributions

During the year, there were no charity contributions (2023: £nil).

Engagement with employees

The Company pursues a policy of meeting with representatives of various sections of employees at which relevant information and developments are discussed. Full and fair consideration is given to applications for employment from disabled persons and to continuing the employment of those who become disabled while employed. The policy is to give equal opportunity for training, career developments and promotion.

Energy and carbon reporting

The Company has taken advantage of the exemption in Part 7A of schedule 7 of the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 from the carbon reporting disclosure as it is a subsidiary undertaking and is included in the consolidated financial statements of Eagle Midco Limited and Eagle Superco Limited. See note 21 for further details.

Page 10

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024

Corporate governance

The Group endeavours to follow high standards of corporate governance, with the board of Eagle Topco Limited (“Board”), the Company’s parent company, determining the governance framework for the whole of the Group, including for the Company. For the year ended 31 December 2024, under the Regulations, the Group has applied the Wates Corporate Governance Principles for Large Private Companies (published by the Financial Reporting Council (FRC) in December 2018 and available on the FRC website) (the Wates Principles).
The Wates Principles provide a framework for the Group to not only demonstrate how the Board makes decisions for the long term success of the Group and its stakeholders, but also have regard to how the Board ensures the Group complies with the requirements of Section 172 of the Companies Act 2016. There has been no departures from the Wates Corporate Governance Principles in the year.

Disclosure of information to auditor

Each of the persons who are directors at the time when this Directors' report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company's auditor is unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditor is aware of that information.

This confirmation is given and should be interpreted in accordance with the provisions of s418 of the Companies Act 2006.
Deloitte LLP are deemed to be reappointed as the Company's auditor s487(2) of the Companies Act 2006.

This report was approved by the board and signed on its behalf.
 





M P Muller
Director

Date: 26 September 2025

1 Lochside Place
Edinburgh
EH12 9DF

Page 11

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024

The directors are responsible for preparing the Strategic report, the Directors' report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 101 ‘Reduced Disclosure Framework’. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the directors are required to:

select suitable accounting policies and then apply them consistently;

make judgments and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Page 12

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

Report on the audit of the financial statements
Opinion
In our opinion the financial statements of Busy Bees Nurseries (Scotland) Limited (the 'company'):
give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its profit for the year then ended; 
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice, including Financial Reporting Standard 101 “Reduced Disclosure Framework”; and
have been prepared in accordance with the requirements of the Companies Act 2006

We have audited the financial statements which comprise:
the profit and loss account; 
the balance sheet;
the statement of changes in equity; and
the related notes 1 to 20.
The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 101 “Reduced Disclosure Framework” (United Kingdom Generally Accepted Accounting Practice).

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor's responsibilities for the audit of the financial statements section of our report.
 
We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the Financial Reporting Council's (the 'FRC's') Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
 
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The other information comprises the information included in the annual report, other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. 

We have nothing to report in this regard.
 
Page 13

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF BUSY BEES NURSERIES (SCOTLAND) LIMITED
 


Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
 
A further description of our responsibilities for the audit of the financial statements is located on the FRC's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Extent to which the audit was considered capable of detecting irregularities, including fraud
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.
 
We considered the nature of the company's industry and its control environment, and reviewed the company's documentation of their policies and procedures relating to fraud and compliance with laws and regulations. We also enquired of management and the directors about their own identification and assessment of the risks of irregularities, including those that are specific to the company's business sector.
 
We obtained an understanding of the legal and regulatory framework that the company operates in, and identified the key laws and regulations that: 
had a direct effect on the determination of material amounts and disclosures in the financial statements. These included the UK Companies Act and tax legislation; and
do not have a direct effect on the financial statements but compliance with which may be fundamental to the company's ability to operate or to avoid a material penalty. 

We discussed among the audit engagement team including relevant internal specialists such as tax, valuations, and IT specialists regarding the opportunities and incentives that may exist within the organisation for fraud and how and where fraud might occur in the financial statements.

In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override. In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments; assessed whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluated the business rationale of any significant transactions that are unusual or outside the normal course of business.
Page 14

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

In addition to the above, our procedures to respond to the risks identified included the following:
reviewing financial statement disclosures by testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;
performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud; 
enquiring of management and in-house legal counsel concerning actual and potential litigation and claims, and instances of non-compliance with laws and regulations; and 
reading minutes of meetings of those charged with governance. 

Report on other legal and regulatory requirements
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified any material misstatements in the strategic report or the directors' report.

Matters on which we are required to report by exception
Under the Companies Act 2006 we are required to report in respect of the following matters if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.

We have nothing to report in respect of these matters.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.





Helen Wildman ACA (Senior statutory auditor) 
For and on behalf of Deloitte LLP
Statutory Auditor
Birmingham, United Kingdom 
26 September 2025


Page 15

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 DECEMBER 2024

2024
2023
Note
£000
£000

  

Turnover
 3 
20,226
19,539

Cost of sales
  
(13,553)
(11,559)

Gross profit
  
6,673
7,980

Administrative expenses
  
(3,821)
(4,062)

Other gains/(loss) on the sale of tangible fixed assets
  
(167)
11

Operating profit
 4 
2,685
3,929

Interest payable and similar expenses
 7 
(378)
(392)

Profit before tax
  
2,307
3,537

Tax on profit
 8 
(48)
(47)

Profit for the financial year
  
2,259
3,490

All amounts relate to continuing activities.
There were no recognised gains and losses for 2024 or 2023 other than those included in the profit and loss account and so no separate statement of other comprehensive income is presented.

The notes on pages 20 to 42 form part of these financial statements.

Page 16

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
REGISTERED NUMBER: SC118818

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£000
£000

  

Fixed assets
  

Intangible assets
 9 
1,660
1,660

Tangible assets
 10 
8,384
8,232

Right of use assets
 11 
4,802
4,009

Amounts owed by group undertakings
 12 
69,056
60,848

  
83,902
74,749

Current assets
  

Debtors
 12 
208
246

Cash at bank and in hand
  
53
27

  
261
273

Creditors: amounts falling due within one year
 13 
(41,588)
(35,851)

Net current liabilities
  
 
 
(41,327)
 
 
(35,578)

Total assets less current liabilities
  
42,575
39,171

  

Creditors: amounts falling due after more than one year
 14 
(7,871)
(6,779)

Deferred taxation
 15 
(329)
(276)

  

Net assets
  
34,375
32,116


Capital and reserves
  

Called up share capital 
 16 
297
297

Share premium account
  
193
193

Capital redemption reserve
  
122
122

Profit and loss account
  
33,763
31,504

  
34,375
32,116


Page 17

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
REGISTERED NUMBER: SC118818
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 26 September 2025.




M P Muller
Director

The notes on pages 20 to 42 form part of these financial statements.

Page 18

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024


Called up share capital
Share premium account
Capital redemption reserve
Profit and loss account
Total equity

£000
£000
£000
£000
£000


At 1 January 2023
297
193
122
28,014
28,626



Profit and total comprehensive income for the year
-
-
-
3,490
3,490



At 1 January 2024
297
193
122
31,504
32,116



Profit and total comprehensive income for the year
-
-
-
2,259
2,259


At 31 December 2024
297
193
122
33,763
34,375


The notes on pages 20 to 42 form part of these financial statements.

Page 19

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.Accounting policies

 
1.1

Basis of preparation of financial statements

Busy Bees Nurseries (Scotland) Limited is a company incorporated in the United Kingdom under the Companies Act 2006. The Company is a private company limited by shares and is registered in Scotland. The address of the Company’s registered office is shown on page 11.
The Company meets the definition of a qualifying entity under Financial Reporting Standard 101 (FRS 101) issued by the Financial Reporting Council. Accordingly, these financial statements are prepared in accordance with Financial Reporting Standard 101 ‘Reduced Disclosure Framework’.
As permitted by FRS 101, the Company has taken advantage of the disclosure exemptions available under that standard in relation to financial instruments, presentation of a cash flow statement, standards not yet effective, certain disclosure in respect of revenue from contracts with customers, impairment of assets, certain related party transactions, and certain disclosure requirements in respect of leases.
The financial statements are prepared under the historical cost convention.

 
1.2

Financial Reporting Standard 101 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions under FRS 101:
 
the Company has adopted a previous GAAP revalued cost as deemed cost for: Goodwill, freehold and long leasehold property; and
the Company has elected to determine whether arrangements contain a lease on the basis of facts and circumstances on the date of transition to FRS 101 rather than when the arrangements were first entered into.
financial instruments as otherwise required by section 8 of FRS 101;
a cash flow statement as otherwise required by section 8 of FRS 101;
key management personnel compensation as otherwise required by paragraph 16 of FRS 101;
The requirements of Paragraphs 30 and 31 of IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors (requirement for the disclosure of information when an entity has not applied a new IFRS that has been issued but is not yet effective);
The requirements of Paragraph 17 of IAS 24 Related Party Disclosures (key management compensation); and
The Company has applied amendments to FRS 101 issued by the FRC in July 2023, for the first time during the year: The amendments introduce a temporary exception to the accounting for deferred tax arising from Pillar Two legislation and require related targeted disclosures.

This information is included in the consolidated financial statements of Eagle Midco Limited as at 31 December 2024 and these financial statements may be obtained from Shaftsbury Drive, Burntwood, Staffordshire, WS7 9QP.

Functional currency
The functional currency is pounds sterling as that is the currency of the economic environment in which the Company operates.

Page 20

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.Accounting policies (continued)

 
1.3

Going concern

In preparation of the financial statements, the directors have made an assessment of the Group’s and the Company’s ability to continue as a going concern. The Company’s business activities, together with the factors likely to affect its future development, performance and position and its exposures to credit risk are set out above. The Company is dependent on the ability of other group companies to settle their obligations to the Company on a timely basis.
The Company made a profit after taxation of £2.3m (2023: £3.5m) and has net assets of £34.4m (2023: £32.1m). The Company is financed through an inter-company facility with other wholly-owned group companies, and there is an unlimited cross guarantee between the Company and other group companies in respect of bank borrowings. 
The Company is reliant on the support of its parent Company, Eagle Superco Limited, to be able to meet its liabilities as they fall due. However, the directors consider that the Company is an integral part of Eagle Superco Limited structure and strategy, which is evidenced by a letter of comfort from Eagle Superco Limited, which states its commitment to provide necessary financial support to ensure that the Company is a going concern for at least twelve months from the date of approval of these financial statements. 
The Group has existing TLB loans of £365.9m and €932.1m under its SFA. In addition, the Group had a £100.0m RCF facility up to 29 August 2025, at which point the facility has been increased to £150.0m. The TLB loans expire in February 2032, the RCF facility expires in August 2031. The TLB loans are a ‘cov-lite’ facility meaning there are no leverage covenant tests on the Group’s financing other than if more than 40% of the Group’s RCF facility is drawn. In this scenario, a leverage covenant of Group indebtedness to EBITDA of 9.85 times would apply.
During the year, the Group drew down on its RCF facility to fund acquisitions completed during the year. The maximum amount drawn at any one time was £38.0m. The amount drawn at 31 December 2024 was £24.0m; an amount of £16.0m is held for bank guarantees leaving available undrawn RCF facility of £60.0m at 31 December 2024. In the year to 31 December 2024 the Group made a loss after tax of £79.7m and has net liabilities of £595.9m, but has EBITDA of £269.9m.
The Group has prepared detailed forecasts for the period up to September 2026 which demonstrate that the Group is able to generate sufficient cash flows to operate within its financing arrangements. These assumptions are made by management based on recent performance, external forecasts and management’s knowledge and expertise of the Group’s cashflow drivers. The Group’s forecasts include the effect of changes in government funding from 2025, increases in employment and other costs realised or expected to be realised during 2025 and 2026 and expected increases in income as a result of planned price increases and expected occupancy growth. The forecast excludes any noncommitted future acquisitions and developments.
The forecast demonstrated that the Group is able to operate within its financing arrangements. The covenant compliance ratio at December 2024 is 4.4:1 vs a maximum ratio of 9.85:1. EBITDA at 31 December 2024, as per lender reporting requirements, would need to fall by 54% in order to breach forecast covenant compliance.

 
Page 21

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.Accounting policies (continued)


1.3
Going concern (continued)

The Group cannot predict the indirect impact of any potential economic slowdown or other events, and the below sensitivities are deemed sufficiently robust in light of current global macro-economic developments in the US following the market response to state enforced tariffs. Having reviewed the Group’s principal risks, the most significant impact on the Group’s cashflows would be a combination of the Group’s principal risks materialising in a temporary or prolonged reduction in occupancy, and consequently, cashflows. The current forecast is based on the Group’s 2025 operating plan and thereafter the Group’s longer term forecasts. 
To assess any potential impact on the Group’s cashflows and liquidity, various sensitivities have been performed reflecting a reduction in occupancy rates, including occupancy falling up to 7% below the current forecast. This reduction in occupancy is considered a reasonable reduction to sensitise the Group’s cashflows as it is based on the Group’s previous experience of occupancy trends following the impact of global economic slowdowns. In combination with sensitising the impact of a fall in occupancy, the Group has also sensitised the Group’s cashflows in 2026 to the specific principal risk of further cost and interest cost increases. Cost increases of a further 2%, from higher than expected employee costs and other supply costs above those already included within the Group’s forecast which reflects all announced UK employment tax changes as at December 2024.
The Group has also sensitised higher than expected interest costs over what has been included in the forecast by modelling a slower than expected fall in SONIA/ EURIBOR rates, with a delay of three months, which is broadly comparable with actual SONIA/ EURIBOR rate performance in 2024. To offset the effect of these items, the Group has modelled the affect of removing planned capital expenditure cashflows on new sites in FY25 and FY26. Under the combination of these sensitivities, and with occupancy falling to 7% below the current forecast, the Group would have a minimum liquidity headroom, inclusive of the available undrawn RCF facility, of £135.2m in the forecast period and would remain in compliance with the leverage test covenant within its SFA. The impact of other mitigating actions, such as reducing development capital expenditure and reducing head office costs, which could protect cashflow and profitability have not been modelled and would be available as further mitigating actions to preserve liquidity.
In the period to August 2025, the Group has performed ahead of forecast in relation to cashflows. At 31 August 2025 the Group has no additional amounts drawn of the RCF, but £16.0m held for guarantees and therefore has £134.0m of available RCF.
As a consequence, the directors believe that the Group is well-placed to manage its business risks successfully and have a reasonable expectation that the Group and Company have adequate resources to continue in operational existence for the foreseeable future, being not less than 12 months from date of approval of these financial statements. Accordingly, the directors continue to adopt the going concern basis in preparing the annual report and financial statements.
After making enquiries and taking account of the factors noted above, the directors have a reasonable expectation that the Company will have access to adequate resources to continue in existence for the foreseeable future. Accordingly, the Company continues to adopt the going concern basis in preparing the annual report and financial statements.

 
1.4

Impact of new international reporting standards, amendments and interpretations

IAS 1 Presentation of Financial Statements - 2020 and 2022 amendments to IAS 1 - Effective 1 January 2024
 
Page 22

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.Accounting policies (continued)

 
1.4

Impact of new international reporting standards, amendments and interpretations (continued)

The amendments introduce a definition of ‘settlement’ which clarifies that settlement refers to the transfer to the counterparty of cash, equity instruments, other assets or services. It also clarifies that the classification of liabilities as current or non-current is based on rights that are in existence at the end of the reporting period. 
The Company has reviewed the amendments and concluded that there is no material impact or changes to financial liability presentation required as a result of the adoption of these amendments.
The Company have reviewed new or revised standards and interpretations issued but not yet effective at the time of signing these financial statements. None of these new or revised standards and interpretations are expected to have a material impact on the Company.

 
1.5

Turnover

Revenue represents the value of services provided, excluding value added tax and is attributable to the Company’s principal activity.
Childcare Services
The principal activity of the Company is the provision of childcare services. The activity is considered as a single performance obligation and revenue from providing these services is recognised over time in the accounting period in which the services are rendered, as the customer simultaneously receives and consumes the benefits of these services over time. Fees for childcare services are paid in advance are recognised as contract liabilities and only recognised in the period to which they relate. Where payments are received from customers in advance of services provided, the amounts are recorded as contract liabilities.
Government funding
Government funding is directly linked to the provision of childcare services, representing additional government funding to supplement the amounts paid by parents. This activity is considered to be linked to the single performance obligation of providing childcare services which is recognised over time as described above. Government funding paid in advance is recognised as contract liabilities and only recognised in the period to which it relates. Where payments are received from funding providers in advance of services provided, the amounts are recorded as contract liabilities.

 
1.6

Interest payable and similar expenses

Interest payable on financial liabilities are recognised in the profit and loss account over the term of such instruments at a constant rate on the carrying amount.

 
1.7

Pensions

The Company contributes to a number of money purchase pension schemes. The assets of the schemes are held separately from those of the Company in an independently administered fund. The pension charge represents the amounts payable by the Company to the schemes during the year. Differences between contributions payable in the year and contributions actually paid are shown as either accruals or prepayments in the balance sheet.

Page 23

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.Accounting policies (continued)

  
1.8

Financial instruments

Financial assets and financial liabilities are recognised in the Company’s statement of financial position when the Company becomes a party to the contractual provisions of the instrument.
Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition.
Financial assets
Debt instruments that meet the following conditions are measured subsequently at amortised cost:
- the financial asset is held within a business model whose objective is to hold financial assets in order to collect contractual cash flows; and
- the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.
(i) Amortised cost and effective interest method
The effective interest method is a method of calculating the amortised cost of a debt instrument and of allocating interest income over the relevant period.
For financial assets other than purchased or originated credit-impaired financial assets (i.e. assets that are credit-impaired on initial recognition), the effective interest rate is the rate that exactly discounts estimated future cash receipts (including all fees and points paid or received that form an integral part of the effective interest rate, transaction costs and other premiums or discounts) excluding expected credit losses, through the expected life of the debt instrument, or, where appropriate, a shorter period, to the gross carrying amount of the debt instrument on initial recognition. For purchased or originated credit-impaired financial assets, a credit-adjusted effective interest rate is calculated by discounting the estimated future cash flows, including expected credit losses, to the amortised cost of the debt instrument on initial recognition.
The amortised cost of a financial asset is the amount at which the financial asset is measured at initial recognition minus the principal repayments, plus the cumulative amortisation using the effective interest method of any difference between that initial amount and the maturity amount, adjusted for any loss allowance. The gross carrying amount of a financial asset is the amortised cost of a financial asset before adjusting for any loss allowance.
Interest income is recognised using the effective interest method for debt instruments measured subsequently at amortised cost. For financial assets other than purchased or originated credit-impaired financial assets, interest income is calculated by applying the effective interest rate to the gross carrying amount of a financial asset, except for financial assets that have subsequently become credit-impaired (see below). For financial assets that have subsequently become credit-impaired, interest income is recognised by applying the effective interest rate to the amortised cost of the financial asset. If, in subsequent reporting periods, the credit risk on the credit-impaired financial instrument improves so that the financial asset is no longer credit-impaired, interest income is recognised by applying the effective interest rate to the gross carrying amount of the financial asset.
Interest income is recognised in profit or loss and is included in the "finance income - interest income" line item.
 
Page 24

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.Accounting policies (continued)

Impairment of financial assets
The Company recognises a loss allowance for expected credit losses on investments in debt instruments that are measured at amortised, lease receivables, trade receivables and other receivables. The amount of expected credit losses is updated at each reporting date to reflect changes in credit risk since initial recognition of the respective financial instrument.
The Company always recognises lifetime ECL (expected credit losses) for trade receivables, contract assets and lease receivables. The expected credit losses on these financial assets are estimated using a provision matrix based on the Company’s historical credit loss experience, adjusted for factors that are specific to the debtors, general economic conditions and an assessment of both the current as well as the forecast direction of conditions at the reporting date, including time value of money where appropriate.
For all other financial instruments, the Company recognises lifetime ECL when there has been a significant increase in credit risk since initial recognition. However, if the credit risk on the financial instrument has not increased significantly since initial recognition, the Company measures the loss allowance for that financial instrument at an amount equal to 12-month ECL.
Lifetime ECL represents the expected credit losses that will result from all possible default events over the expected life of a financial instrument. In contrast, 12-month ECL represents the portion of lifetime ECL that is expected to result from default events on a financial instrument that are possible within 12 months after the reporting date.
(i) Significant increase in credit risk
In assessing whether the credit risk on a financial instrument has increased significantly since initial recognition, the Company compares the risk of a default occurring on the financial instrument at the reporting date with the risk of a default occurring on the financial instrument at the date of initial recognition. In making this assessment, the Company considers both quantitative and qualitative information that is reasonable and supportable, including historical experience and forward-looking information that is available without undue cost or effort. Forward-looking information considered includes the future prospects of the industries in which the Company’s debtors operate, obtained from economic expert reports, financial analysts, governmental bodies, relevant think-tanks and other similar organisations, as well as consideration of various external sources of actual and forecast economic information that relate to the Company’s core operations.
In particular, the following information is taken into account when assessing whether credit risk has increased significantly since initial recognition:
- an actual or expected significant deterioration in the financial instrument’s external (if available) or internal credit rating;
- significant deterioration in external market indicators of credit risk for a particular financial instrument, e.g. a significant increase in the credit spread, the credit default swap prices for the debtor, or the length of time or the extent to which the fair value of a financial asset has been less than its amortised cost;
- existing or forecast adverse changes in business, financial or economic conditions that are expected to cause a significant decrease in the debtor’s ability to meet its debt obligations;
-  an actual or expected significant deterioration in the operating results of the debtor; and
- an actual or expected significant adverse change in the regulatory, economic, or technological environment of the debtor that results in a significant decrease in the debtor’s ability to meet its debt obligations.
 
Page 25

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.Accounting policies (continued)

Financial liabilities
Debt and equity instruments are classified as either financial liabilities or as equity in accordance with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.
All financial liabilities are measured subsequently at amortised cost using the effective interest method or at FVTPL.
Financial liabilities that are not (i) contingent consideration of an acquirer in a business combination, (ii) held-for-trading, or (iii) designated as at FVTPL, are measured subsequently at amortised cost using the effective interest method.
The effective interest method is a method of calculating the amortised cost of a financial liability and of allocating interest expense over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash payments (including all fees and points paid or received that form an integral part of the effective interest rate, transaction costs and other premiums or discounts) through the expected life of the financial liability, or (where appropriate) a shorter period, to the amortised cost of a financial liability.
Derecognition of financial liabilities
The Company derecognises financial liabilities when, and only when, the Company’s obligations are discharged, cancelled or have expired. The difference between the carrying amount of the financial liability derecognised and the consideration paid and payable is recognised in profit or loss.
When the Company exchanges with the existing lender one debt instrument into another one with the substantially different terms, such exchange is accounted for as an extinguishment of the original financial liability and the recognition of a new financial liability. Similarly, the Company accounts for substantial modification of terms of an existing liability or part of it as an extinguishment of the original financial liability and the recognition of a new liability. It is assumed that the terms are substantially different if the discounted present value of the cash flows under the new terms, including any fees paid net of any fees received and discounted using the original effective rate is at least 10 per cent different from the discounted present value of the remaining cash flows of the original financial liability. If the modification is not substantial, the difference between: (1) the carrying amount of the liability before the modification; and (2) the present value of the cash flows after modification is recognised in profit or loss as the modification gain or loss within other gains and losses.

Page 26

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.Accounting policies (continued)

 
1.9

Impairment of assets

At each reporting period date, the Company reviews the carrying amounts of its property plant and equipment, right-of-use assets, and finite lived intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. For the purpose of impairment testing, the recoverable amount (that is, higher of the fair value less costs to sell and the value-in-use) is determined on an individual asset basis, unless the asset does not generate cash flows that are largely independent of those from other assets, in which case the recoverable amount is determined at the cash generating unit level to which the said asset belongs. If such individual assets or cash generating units are considered to be impaired, the impairment is recognised in the statement of comprehensive income is measured by the amount by which the carrying value of the asset or cash generating unit exceeds their estimated recoverable amount and allocated on pro-rata basis.
Impairment losses are reversed in the profit and loss account and the carrying value is increased to its revised recoverable amount provided that this amount does not exceed the carrying value that would have been determined had no impairment loss been recognised for the said asset or cash generating unit in previous years.

  
1.10

Intangible assets - goodwill

Goodwill recognised on the acquisition of subsidiary businesses is not amortised but is reviewed for impairment annually or more frequently if events or changes in circumstances indicate that the carrying value may be impaired. For the purpose of impairment testing, cash- generating units are aggregated into groups of cash-generating units. A cash generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or group of assets. Goodwill is allocated to each of the Company’s groups of cash-generating units expected to benefit from the synergies of the relevant business combination. The impairment review requires management to consider the recoverable value of the group of cash-generating units to which the goodwill relates, based on either the fair value less costs to sell or the value in use. Value in use calculations require management to consider the net present value of future cash flows generated by the group of cash-generating units to which the goodwill relates. Fair value less costs to sell is based on management’s estimate of the net proceeds which could be generated through disposing of that group of cash-generating units. If the recoverable amount of the group of cash-generating units is less than the carrying amount of the group of cash-generating units, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the group of cash-generating units and then to the other assets of the group of cash-generating units pro-rata on the basis of the carrying amount of each cash-generating unit in the group of cash-generating units. An impairment loss is recognised immediately in the profit and loss account and is not subsequently reversed. In line with IFRS 3 goodwill is not amortised, this is a departure from the Companies Act 2006.

 
1.11

Intangible assets – brand names & customer relationships.

Other intangible assets arising on the acquisition of subsidiary undertakings and businesses relate to customer databases and contracts, and brand names. Intangible assets are carried at cost less accumulated amortisation and any impairment losses. Intangible assets arising on an acquisition are recognised separately from goodwill if the fair value of these assets can be identified separately and measured reliably. Amortisation is calculated on a straight-line basis over the estimated useful life of the intangible asset. The estimated useful life of both brand names and customer relationships is five years. Impairment reviews are carried out more frequently if events or changes in circumstances indicate that the carrying value of an asset may be impaired. Any impairment of carrying value is charged to the profit and loss account.

Page 27

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.Accounting policies (continued)

 
1.12

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

The estimated useful lives range as follows:

Freehold and long leasehold buildings
-
over the 50 years with an expected residual value of 50%
Short-term leasehold property
-
over the period of the lease
Centre and office equipment
-
over four years
Motor vehicles
-
over four years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset was already of the age and in the condition expected at the end of its useful life

 
1.13

Leases

Leases
The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by using the rate implicit in the lease. If this rate cannot be readily determined, the Company uses its incremental borrowing rate.
Lease payments included in the measurement of the lease liability comprise:
 
Fixed lease payments (including in-substance fixed payments), less any lease incentives receivable;
Variable lease payments that depend on an index or rate, initially measured using the index or rate at the commencement date;
The amount expected to be payable by the lessee under residual value guarantees;
The exercise price of purchase options, if the lessee is reasonably certain to exercise the options; and
Payments of penalties for terminating the lease, if the lease term reflects the exercise of an option to terminate the lease.

The lease liability is presented as a separate line in the consolidated statement of financial position. The lease liability is subsequently measured by increasing the carrying amount to reflect interest on the lease liability (using the effective interest method) and by reducing the carrying amount to reflect
Page 28

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.Accounting policies (continued)


1.13
Leases (continued)

the lease payments made.
The Company remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever:

The lease term has changed or there is a significant event or change in circumstances resulting in a change in the assessment of exercise of a purchase option, in which case the lease liability is remeasured by discounting the revised lease payments using a revised discount rate.
The lease payments change due to changes in an index or rate or a change in expected payment under a guaranteed residual value, in which cases the lease liability is remeasured by discounting the revised lease payments using an unchanged discount rate (unless the lease payments change is due to a change in a floating interest rate, in which case a revised discount rate is used).
A lease contract is modified and the lease modification is not accounted for as a separate lease, in which case the lease liability is remeasured based on the lease term of the modified lease by discounting the revised lease payments using a revised discount rate at the effective date of the modification.

The right-of-use assets comprise the initial measurement of the corresponding lease liability, lease payments made at or before the commencement day, less any lease incentives received and any initial direct costs. They are subsequently measured at cost less accumulated depreciation and impairment losses.
Whenever the Company incurs an obligation for costs to dismantle and remove a leased asset, restore the site on which it is located or restore the underlying asset to the condition required by the terms and conditions of the lease, a provision is recognised. To the extent that the costs relate to a right-of-use asset, the costs are included in the related right-of-use asset, unless those costs are incurred to produce inventories.
 
Right-of-use assets are depreciated over the shorter period of lease term and useful life of the underlying asset. If a lease transfers ownership of the underlying asset or the cost of the right-of-use asset reflects that the Company expects to exercise a purchase option, the related right-of-use asset is depreciated over the useful life of the underlying asset. The depreciation starts at the commencement date of the lease.
 
The right-of-use assets are presented as a separate line in the statement of financial position.
 
The Company applies IAS 36 to determine whether a right-of-use asset is impaired and accounts for any identified impairment loss as described in the ‘Property, Plant and Equipment’ policy.
 
Variable rents that do not depend on an index or rate are not included in the measurement the lease liability and the right-of-use asset. The related payments are recognised as an expense in the period in which the event or condition that triggers those payments occurs and are included in the line “Other operating expenses” in profit or loss).

Page 29

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.Accounting policies (continued)

  
1.14

Sale and leaseback

Sale and leaseback transactions are accounted based on the principle of determining whether control over the properties has transferred to the Purchaser. The Company considers the sale as not an effective transfer of control of these properties and accordingly does not derecognise the transferred asset. The consideration received on transfer of property is recognised as a secured borrowing. This borrowing is a financial liability and is measured on an amortised cost basis using effective interest rate.

  
1.15

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to income or to assets. Grants relating to assets are deferred and credited to the profit and loss account as the related asset is depreciated. Grants relating to income are recognised as income over the period in which the related costs are recognised. Grants relating to income are recognised in revenue if they relate to Government grant income directly linked to the provision of childcare services, representing additional government funding to supplement the amounts paid by parents.

 
1.16

Current and deferred taxation

Current UK corporation tax is provided at amounts expected to be paid (or recovered) using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Current tax assets and liabilities are offset only when there is a legally enforceable right to set off the amounts and the company intends either to settle on a net basis or to realise the asset and settle the liability simultaneously.
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events that result in an obligation to pay more tax or a right to pay less tax in the future have occurred at the balance sheet date. Timing differences are differences between the company's taxable profits and its results as stated in the financial statements that arise from the inclusion of gains and losses in tax assessments in periods different from those in which they are recognised in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that, on the basis of all available evidence, it can be regarded as more likely than not that there will be suitable taxable profits from which the future reversal of the underlying timing differences can be deducted.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date that are expected to apply to the reversal of the timing difference. Deferred tax relating to property, plant and equipment carried at deemed cost is provided based on the difference between the financial statements and tax base costs. Deferred tax assets and liabilities are offset only if the Company has a legally enforceable right to set off current tax assets against current tax liabilities.

  
1.17

Provisions

Provisions are recognised when there is a present obligation as a result of a past event, and it is probable that the Company will be required to settle that obligation. Provisions are measured at the directors’ best estimate of the expenditure required to settle the obligation at the balance sheet date and are discounted to present value where the effect is material.

Page 30

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.


Judgments in applying accounting policies and key sources of estimation uncertainty

In the application of the Company’s accounting policies, which are described in note 1, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from the sources. The estimates and assumptions relate to provisioning against receivables and recognition of grant income. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future period if the revision affects both current and future periods. The Company does not have any significant sources of, or items, of estimation uncertainty. 
Critical accounting judgements:
Classification of sale and leaseback transaction
The sale and leaseback transactions, carried out primarily during 2017 and also in 2018, involves the legal form of a lease. It is necessary to determine whether the associated transactions are linked and whether the arrangement meets the form of a lease under FRS 101. The directors have concluded based on the facts and circumstances that the sale and leaseback transaction does not meet the requirement of a sale and leaseback transaction under FRS 101, due to buyback provisions within the lease contract with another Group entity. As a result, the Company has a right of use asset and lease liability in relation to a lease held between the Company and another Group entity. The transaction has been treated consistently in each year end since 31 December 2017.
In 2021, the Company completed a sale and leaseback transaction which involved the legal form of a lease property. It is necessary to determine whether the associated transactions are linked and whether the arrangement meets the form of a lease under FRS 101. The directors have concluded based on the facts and circumstances that the sale and leaseback transaction does not meet the requirement of a sale and leaseback transaction under FRS 101, due to buyback provisions for the Company within the lease contract. As a result, the Company has not derecognised the assets under the lease and has recognised a financial liability in relation to the amount received by the Company from the sale and leaseback transaction.
Determining the lease term
Under IFRS 16 if it is reasonably certain that a lease will be extended, the Company is required to estimate the expected lease period in excess of the current contractual terms. The Company has various lease agreements with a right to extend or renew wherein it considers the nature of the contractual terms and economic factors to determine. The Company has used judgement in determining the lease period considering such factors and the lease liability has been calculated using the remaining contractual lease period for all of such lease contracts.

Page 31

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

3.


Turnover

An analysis of the Company's turnover, which all arises within the United Kingdom, by class of business is as follows:


2024
2023
£000
£000

Childcare services and Government funding
20,226
19,539



4.


Operating profit

The operating profit is stated after charging/(crediting):

2024
2023
£000
£000

Depreciation of tangible fixed assets
1,005
879

Loss/(profit) on the sale of tangible fixed assets
167
(11)

Depreciation of right of use assets
601
637

Impairment of tangible fixed assets
77
-

Impairment of right of use assets
61
-

The fees payable to the Company’s auditor for the audit of the Company’s annual financial statements of £32,000 (2023: £28,000) and fees payable to the Company’s auditor and their associates for other services to the Company of £nil (2023: £nil) were borne by another Group company.

Page 32

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

5.


Employees

Staff costs were as follows:


2024
2023
£000
£000

Wages and salaries
11,114
9,400

Social security costs
808
608

Pension
203
162

12,125
10,170


The average monthly number of employees, including the directors, during the year was as follows:


        2024
        2023
            No.
            No.







Administrative and management
36
38



Childcare
355
348

391
386


6.


Directors' remuneration

The directors were remunerated in the current and prior year by fellow Group companies. All directors were renumerated by Busy Bees Holdings Limited. It is not considered practical or possible to accurately apportion these costs to each entity in the Group. Given the relative size of the respective entities, the effect of not apportioning these costs for disclosure purposes is not considered to be material.




7.


Interest payable and similar expenses

2024
2023
£000
£000


Interest on lease liabilities
378
392

Page 33

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

8.


Taxation


2024
2023
£000
£000

Corporation tax


Adjustments in respect of previous periods
(4)
(17)


Total current tax
(4)
(17)

Deferred tax


Current year
47
51

Adjustment in respect of previous periods
5
8

Effect of changes in tax rates
-
5

Total deferred tax
52
64


Tax charge for the year
48
47

Factors affecting tax charge for the year

The tax assessed for the year is lower than (2023 - lower than) the standard rate of corporation tax in the UK of 25.00% (2023 - 23.52%). The differences are explained below:

2024
2023
£000
£000


Profit before tax
2,307
3,537


Profit before tax multiplied by standard rate of corporation tax in the UK of 25.00% (2023 - 23.52%)
577
832

Effects of:


Expenses not deductible for tax purposes,
43
126

Adjustments to tax charge in respect of prior periods
1
(8)

Income not taxable
(10)
(2)

Tax rate changes
-
2

Group relief obtained for nil consideration
(620)
(943)

Exempt amounts
57
41

Super deduction
-
(1)

Total tax charge for the year
48
47

Page 34

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
 
8.Taxation (continued)


Factors that may affect future tax charges

The standard rate of tax applied to the reported loss on ordinary activities is 25.00% (2023: 23.52%). At 31 December 2024 the Company had £336,000 (2023: £336,000) of unrecognised deferred tax assets which relate to fixed assets and losses. There is no expiry date on the unrecognised deferred tax assets.
The Company has applied the amendments made to FRS 101 that introduce a temporary exception to the accounting and disclosure for deferred tax, or potential income tax consequences arising from Pillar Two legislation. Disclosures relating to the potential income tax consequences of Pillar Two legislation on the Group are disclosed within the Group’s financial statements. Accordingly, the Company neither recognises nor discloses information about deferred tax assets and liabilities related to Pillar Two income taxes.


9.


Intangible assets




Goodwill
Brand names
Customer relationships
Total

£000
£000
£000
£000



Cost


At 1 January 2024
1,705
132
933
2,770



At 31 December 2024

1,705
132
933
2,770



Amortisation


At 1 January 2024
45
132
933
1,110



At 31 December 2024

45
132
933
1,110



Net book value



At 31 December 2024
1,660
-
-
1,660



At 31 December 2023
1,660
-
-
1,660




Page 35

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

10.


Tangible fixed assets





Freehold and long leasehold property
Short-term leasehold property
Centre and office equipment
Motor vehicles
Total

£000
£000
£000
£000
£000



Cost or valuation


At 1 January 2024
6,319
1,720
4,412
4
12,455


Additions
-
-
1,411
-
1,411


Disposals
-
(165)
(1,924)
-
(2,089)



At 31 December 2024

6,319
1,555
3,899
4
11,777



Depreciation


At 1 January 2024
438
1,179
2,602
4
4,223


Charge for the year on owned assets
54
111
840
-
1,005


Disposals
-
(110)
(1,802)
-
(1,912)


Impairment charge
-
20
57
-
77



At 31 December 2024

492
1,200
1,697
4
3,393



Net book value



At 31 December 2024
5,827
355
2,202
-
8,384



At 31 December 2023
5,881
541
1,810
-
8,232

During the year, the Company carried out an impairment review of its centres. The review led to the recognition of an impairment of £77,000 (2023: £nil). The impairment/reversal recognised for any individual centre is sensitive to changes in the estimated cashflows within the value in use calculation and changes to the discount rate used to discount those cashflows, the results of sensitivity analysis performed are disclosed in note 11.
Forecast operating cash flows are post tax and have been discounted using a post tax discount rate but in line with best practice have disclosed the pre-tax discount rate used of 10.2% (2023: 10.4%). 
The freehold land and buildings have a net book value of £4.1m (2023: £4.2m). The long leasehold land and buildings has a net book value of £1.7m (2023: £1.7m).

Page 36

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

11.


Leases

This note provides information for leases where the Company is a lessee.
i) Amounts recognised in the balance sheet


2024
2023
£000
£000

Right of use assets


Land and buildings
4,802
4,009

Additions in the year, amounted to £1,417,000 (2023: £44,000).

2024
2023
£000
£000

Lease liabilities


Non-current (note 16)
6,938
5,910

Current (note 15)
631
849

7,569
6,759

ii) Amounts recognised in the profit and loss account


2024
2023
£000
£000

Depreciation charge of Right of Use Assets


Land and buildings

601
637




Interest expense included in interest payable
378
392

Net impairment charge
61
-

Page 37

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

Leases (continued)
The total cash outflow for leases was £909,000 (2023: £991,000). The Company does not sub lease any of its leased assets.
There are no expenses relating to either short term or low value leases (2023: £nil).
The Company leases centres, various offices, equipment and vehicles. Rental contracts are typically made for fixed periods of typically ten years but may have extension options as described below. Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions. The lease agreements do not impose any covenants other than the security interests in the leased assets that are held by the lessor. Leased assets may not be used as security for borrowing purposes.
Payments associated with short-term leases of equipment and vehicles and all leases of low-value assets are recognised on a straight-line basis as an expense in the Profit and loss account. Short-term leases are leases with a lease term of 12 months or less without a purchase option. Low-value assets comprise small items of office furniture and IT.
Extension and termination options are included in a number of property and equipment leases across the Company. These are used to maximise operational flexibility in terms of managing the assets used in the Company’s operations. The majority of extension and termination options held are exercisable only by the Company and not by the respective lessor.
The Company has no variable lease payments.
Impairment
During the year, the Company carried a review of the recoverable amount of its cash generating units, which the Directors define as individual centres, further details on this review are provided in Note 12. Impairments were required on a number of closed or loss making centres as well as the reversal of some previous impairment where centre performance has improved and this is expected to continue. For the year ended 31 December 2024, an impairment charge of £61,000 (2023: £nil) has been recognised against right of use assets. 
Sensitivity analysis has been undertaken to determine the sensitivity of the headroom on the Company’s CGUs. A plausible downside analysis has been performed by assuming that occupancy and efficiency remains at 2024 actual amounts in the forecast period; this analysis modelled a decrease in estimated cashflows, in this analysis there was £134,000 of fixed asset impairment and £315,000 of right of use assets impairment.




Contractual undiscounted cash flows are due as follows:

2024
2023
£000
£000

Between one year and five years
4,069
3,834

Later than five years
5,059
2,779

9,128
6,613


Page 38

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

12.


Debtors


2024
2023
£000
£000

Amounts falling due within one year:

Trade debtors
14
38

Other debtors
2
-

Prepayments and accrued income
192
208

208
246


2024
2023
£000
£000

Amounts falling due in more than one year:


Amounts owed by group undertakings
69,056
60,848

There is no repayment date attached to the amount owed by group undertakings but these are not expected to be settled in the next 12 months. There was no interest charged on the amounts owed by group undertakings (2023: 0%).


13.


Creditors: Amounts falling due within one year

2024
2023
£000
£000

Trade creditors
433
307

Amounts owed to group undertakings
37,956
32,069

Corporation tax
-
4

Other taxation and social security
191
169

Lease liabilities
631
849

Other creditors
995
883

Accruals and deferred income
1,382
1,570

41,588
35,851


Page 39

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

13.Creditors: Amounts falling due within one year (continued)

There is no repayment date attached to the amount owed to group undertakings, but they are repayable on demand. There was no interest charged on the amounts owed to group undertakings (2023: 0%).
Included within the accruals and deferred income balance is £461,000 of fees in advance (2023: £416,000). Included within other creditors are deposits from parents of £33,000 (2023: £23,000), both of which are considered to be contract liabilities. During the year, £416,000 of fees in advance recognised at the previous reporting date were recognised as income. £461,000, being fees in advance and 93% of the contract liabilities balance at 31 December 2024, is expected to be recognised in the year ended 31 December 2024. The remainder of the balance relates to deposits from parents which is expected to be repaid to parents when their contractual arrangement with the Company ceases which is unknown.


14.


Creditors: Amounts falling due after more than one year

2024
2023
£000
£000

Secured loans
933
869

Lease liabilities
6,938
5,910

7,871
6,779


Secured loans relate to amounts received in relation to transactions completed by the Company related to the sale of freeholds of some of the Company’s UK centres. The secured loan is secured on 1 (2023: 1) of the Company’s UK centres.

The aggregate amount of liabilities repayable wholly or in part more than five years after the balance sheet date is:

2024
2023
£000
£000

Lease liabilities

Repayable by instalments
5,059
2,779

5,059
2,779

Other liabilities

Repayable by instalments
933
869

933
869

Total amounts due after more than five years
5,992
3,648



Page 40

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

15.


Deferred taxation




2024
2023


£000

£000






At beginning of year
(276)
(216)


Charged to profit or loss
(53)
(60)



At end of year
(329)
(276)

Deferred tax balances have been calculated based on the rates at the date of restatement that will apply when the timing differences are expected to reverse. Accordingly, a rate of 25.0% has been used as at 31 December 2024 (2023: 25%). The Group and Company has applied the temporary exception issued by the IASB in May 2024 from the accounting requirements for deferred taxes in IAS 12. Accordingly, the  Company neither recognises nor discloses information about deferred tax assets and liabilities related to Pillar Two income taxes. The deferred tax provision is as follows and all items are expected to reverse within 12 months.

The provision for deferred taxation is made up as follows:

2024
2023
£000
£000


Property, plant and equipment
(341)
(286)

Short-term timing differences
12
10

(329)
(276)


16.


Share capital

2024
2023
£000
£000
Authorised, allotted, called up and fully paid



297,194 (2023 - 297,194) Ordinary shares of £1 each
297
297

The Company’s other reserves are as follows:
The share premium reserve contains the premium arising on issue of equity shares, net of issue expenses.
The capital reserve contains the nominal value of own shares that have been acquired by the Company and cancelled.
The profit and loss account represents cumulative profits and losses net of dividends paid and other adjustments.


Page 41

 
BUSY BEES NURSERIES (SCOTLAND) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

17.


Pension commitments

The Company operates a money purchase scheme for the benefit of certain employees. Contributions are charged to the profit and loss account in the year to which they relate. The charge in the year was £203,000 (2023: £162,000). At 31 December 2024 there was £51,000 outstanding, still to be paid (2023: £39,000).


18.Other financial commitments

(a)  The Company had no capital commitments at 31 December 2024 (2023: £nil).
(b) The Company provides an unlimited cross guarantee to other group companies in respect of bank borrowings. Total group and company bank borrowings at 31 December 2024 are £1,066.8m (2023: £1,111.8m.


19.


Related party transactions

The company has taken the exemption available under FRS 101 not to disclose related party transactions with other 100% controlled members of the same group. There were no other related party transactions in the year.


20.


Controlling party

The Company’s immediate parent undertaking is Busy Bees Holdings Limited. The largest group into which the Company is consolidated is the group headed by Eagle Superco Limited and the smallest group into which the Company is consolidated is the group headed by Eagle Midco Limited. Busy Bees Holdings Limited, Eagle Superco Limited and Eagle Midco Limited are all incorporated in Great Britain and registered at Shaftsbury Drive, Burntwood, Staffordshire, WS7 9QP. The consolidated financial statements of Eagle Superco Limited can be obtained from the Company’s registered address above. The ultimate parent Company is Eagle Superco Limited and the ultimate controlling party is the Ontario Teachers’ Pension Plan incorporated in Canada, its registered address is 5650 Yonge Street, Toronto, Ontario, M2M 2H5.

Page 42